PAI‐1 5G/5G genotype is an independent risk of intracranial hemorrhage in post‐lysis stroke patients

OBJECTIVE: Thrombolysis by recombinant tissue plasminogen activator (rt‐PA) is the main pharmacological therapy in acute ischemic stroke (IS); however, it is only effective in a subset of patients. Here we aimed to investigate the role of plasminogen activator inhibitor‐1 (PAI‐1), an effective inhib...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Ann Clin Transl Neurol
Glavni autori: Szegedi, István, Nagy, Attila, Székely, Edina G., Czuriga‐Kovács, Katalin R., Sarkady, Ferenc, Lánczi, Levente I., Berényi, Ervin, Csiba, László, Bagoly, Zsuzsa
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2019
Teme:
Research Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6856768/
https://ncbi.nlm.nih.gov/pubmed/31637872
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.50923
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items